Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FZX50
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,511
Award facts
- Contract value 100% obligated
- $2,510.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order on July 26, 2025, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Exparel 266 mg/20 ml vials. The contract is valued at $2,510.63 on a firm fixed-price basis with an ultimate completion date of August 15, 2025. This delivery order was awarded without a set-aside designation, leveraging the vendor's competitive positioning as a small business in the federal pharmaceutical procurement market.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026. The IDC, designated SPE2DB, authorizes the agency to issue firm fixed-price delivery orders for pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities. Exparel, a liposomal bupivacaine product used for local anesthetic infiltration and nerve blocks, represents one of the specialized pharmaceutical items within the contract's extensive portfolio that includes branded and generic prescription drugs, biologics, and medical consumables.
Quick answers
Who was awarded contract SPE2DB25FZX50?
SPE2DB25FZX50 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 26, 2025.
How much is contract SPE2DB25FZX50 worth?
The government has obligated $2,511 on SPE2DB25FZX50.
Is contract SPE2DB25FZX50 an order under another contract?
Yes. SPE2DB25FZX50 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX50 competed?
The extent of competition for SPE2DB25FZX50 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award